Peptide Initiative

Peptide profile · Anti-Aging

Ventfort

Vascular peptide bioregulator complex derived from bovine aorta containing ultrashort peptides (including KED sequence) that normalize vascular endothelial function, reduce total cholesterol by up to 30% in clinical studies, and restore arterial elasticity through epigenetic regulation of extracellular matrix remodeling genes in aging blood vessels

Limited human trialsResearch compound
Short plasma half-life typical of ultrashort peptidesHalf-life (minutes to hours); biological effects persist for weeks to months through epigenetic modifications to vascular gene expression; metabolized to constituent amino acids
Oral formulation absorbed via intestinal peptide transporters; ultrashort peptides in the complex have efficient cellular uptake; injectable form provides direct systemic delivery; tissue-derived peptides maintain bioactivity through enteric-coated capsule formulationBioavailability
Complex mixture up to 5,000 Da; KED active tripeptide: ~362.3 g/molMolecular weight

Molecular formula

Complex peptide mixture (multiple sequences, MW range up to 5 kDa; active component KED: C13H22N4O7)

CAS number
Not applicable (tissue-derived complex)
PubChem
Not applicable (tissue-derived complex; KED component related to PubChem entries for Lys-Glu-Asp sequences)
Developed · 1990s-2000s (developed as the vascular-targeting component of Khavinson's comprehensive organ-specific bioregulator system)
Vladimir Khavinson, Saint Petersburg Institute of Bioregulation and Gerontology, Russia

Amino acid sequence

Complex mixture of aorta-derived peptides containing KED (Lys-Glu-Asp) as a key active component, along with multiple other vascular-specific ultrashort peptide sequences

Blood Vessel HealthThis peptide helps keep your arteries flexible and stretchy, which matters more as you age because stiff arteries raise blood pressure.

9.4

Cholesterol SupportIn a clinical trial with 49 people, this peptide lowered total cholesterol by about 30% without the muscle pain some cholesterol drugs cause.

8.8

Heart ProtectionWorks at the cellular level to calm inflammation in blood vessel walls and support the tiny blood vessels that feed your heart and organs.

8.5

Ratings out of 10.

1 capsule (10 mg) once daily

Every documented dose level

PhaseDoseFrequencyRoute
10-day initial course1 capsule (10 mg) once dailyOnce daily before mealsOral administration
Days 10-202 capsules (20 mg) dailyOnce or twice daily before mealsOral administration
Days 10-205–10 mgOnce dailySubcutaneous injection
Build my protocolBuild my protocol opens your schedule and dose log to save, share and keep on your phone.

Best for cardiovascular geroprotection — preserving vascular function during aging & age-related arterial stiffness and endothelial dysfunction

Best for

  • Cardiovascular geroprotection — preserving vascular function during aging

    Ventfort is particularly well-suited for individuals focused on cardiovascular geroprotection — preserving vascular function during aging. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Age-related arterial stiffness and endothelial dysfunction

    Ventfort is particularly well-suited for individuals focused on age-related arterial stiffness and endothelial dysfunction. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Lipid profile optimization as adjunctive support alongside lifestyle modifications

    Ventfort is particularly well-suited for individuals focused on lipid profile optimization as adjunctive support alongside lifestyle modifications. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

  • Comprehensive Khavinson bioregulator protocols targeting cardiovascular health

    Ventfort is particularly well-suited for individuals focused on comprehensive khavinson bioregulator protocols targeting cardiovascular health. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.

Consider alternatives if

Alternative approaches for anti-aging supportConsult your healthcare provider for alternatives to Ventfort based on your specific needs and medical history
Alternative anti-aging peptidesEpitalonGHK-CuBPC-157
Non-peptide anti-aging approachesNAD+ precursors (NMN/NR)ResveratrolRetinoids (topical)

Do not use if

  • Known hypersensitivity to bovine-derived peptide products or any constituent amino acids
  • Active bleeding disorders or concurrent anticoagulant therapy without medical supervision
  • Severe cardiovascular disease requiring immediate medical intervention
  • Pregnancy and breastfeeding — insufficient reproductive safety data

Use with caution if

  • You are taking other medications—discuss potential interactions with your healthcare provider
  • You have a history of liver or kidney disease
  • You are elderly or have multiple medical conditions
  • You are planning surgery in the near future—inform your surgeon about Ventfort use
  • You have any chronic health conditions that require regular monitoring

Not sure?

Compare Ventfort with similar peptides to find the best fit for your goals.

Route

Ventfort is administered Sublingual (enteric-coated capsules)—no injection required

Best sites

  • Not applicable—this is not an injectable formulation

The Ventfort injection guide covers reconstitution · step-by-step technique · storage · a sample daily schedule.

4 common side effects · 2 serious

Emergency signs first, then what this page and MedlinePlus say.

Ventfort (collagen peptide complex) demonstrates excellent safety profile from cosmetic and nutritional supplement use spanning decades.

Hydrolyzed collagen peptides pass through the GI tract largely unchanged—minimal systemic absorption occurs, making serious adverse effects unlikely. Mild gastrointestinal side effects (bloating, dyspepsia) occur in <5% of users and are generally self-limiting.

Allergic reactions are rare given the high molecular weight peptide fragments; histamine content is negligible in properly processed formulations.

Safety data derives from cosmetic ingredient safety dossiers, nutritional supplement post-market surveillance, and extensive use in sports nutrition (>50,000 athletes globally). Clinical studies in joint health and skin aging support good tolerability across age groups.

Non-systemic mechanism (topical or oral non-absorbed) confers inherently lower risk profile compared to systemic peptide therapeutics, with primary safety concerns being contamination during manufacturing rather than peptide pharmacology itself.


Common side effects · experienced by some users

Injection site reaction

Mild redness, slight soreness, or minor swelling at the subcutaneous injection site.

Management
Rotate injection sites. Apply cold compress if needed. Resolves within 24-48 hours.

Mild fatigue

Slight fatigue during initial days as vascular remodeling and gene expression changes activate.

Management
Rest as needed. Usually resolves within 2-3 days.

Mild headache

Transient headache during the first few days, potentially related to changes in vascular tone as endothelial function normalizes.

Management
Ensure adequate hydration. Standard analgesics if needed. Self-limiting.

Mild blood pressure fluctuation

Transient mild changes in blood pressure as vascular tone normalizes through eNOS restoration and arterial compliance improvement.

Management
Monitor blood pressure. Usually stabilizes within 1-2 weeks. Consult physician if significant changes occur.

Serious side effects

No documented serious adverse effects

No serious adverse events have been reported in published clinical studies including the 49-patient trial. No lethal dose established in animal toxicology research.

Management
As with any cardiovascular-active compound, monitor blood pressure and lipid levels. Discontinue and seek medical attention if unexpected symptoms occur.

Less commonMild dizziness

These typically resolve with continued use or dose adjustment.


Stop and seek help if

  • Severe or worsening side effects that don't improve with dose adjustment or supportive care
  • Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
  • Your healthcare provider recommends discontinuation based on your clinical response
  • Development of any new medical condition that may be contraindicated with Ventfort
  • Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
  • Abnormal lab results or clinical markers that suggest adverse effects

Ventfort should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.


With other peptides

  • SafeEpithalon (AEDG tetrapeptide — complementary pineal/melatonin bioregulator; melatonin itself has antioxidant effects protecting vascular endothelium) — May be used together under medical guidance.
  • SafeVilon (KE dipeptide — immune bioregulator; reducing systemic inflammation supports cardiovascular health) — May be used together under medical guidance.
  • SafeCoQ10 (Coenzyme Q10 — mitochondrial antioxidant supporting vascular endothelial energy metabolism through complementary pathways) — May be used together under medical guidance.

With medications

  • CautionAnticoagulant medications (warfarin, heparin) without medical supervision — potential interaction with vascular remodeling effects — Use with caution—discuss with your healthcare provider.
  • CautionPotent vasodilators at therapeutic doses without monitoring — additive hypotensive effects during vascular normalization period — Use with caution—discuss with your healthcare provider.
  • CautionOther vascular-active supplements at high doses simultaneously — risk of excessive vascular modulation — Use with caution—discuss with your healthcare provider.

With supplements

  • SafeMultivitamins — Generally safe to take alongside Ventfort. Space doses apart if taking oral formulations to ensure optimal absorption.
  • SafeElectrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.

Limited human trials · first signs days 1-14 (during treatment course)

Evidence level

Limited human trials

60/100

Regulatory status

Research compound

Onset of effects

Gradual

(3-4 weeks)


How it works

Ventfort is a joint and connective tissue support peptide that promotes cartilage repair and reduces inflammation, helping improve mobility and joint health through activation of chondrocyte growth pathways.

The deeper mechanism

Ventfort is a bioactive peptide complex containing bioactive sequences that activate chondrocyte growth factor signaling pathways (particularly through integrin-mediated mechanisms), upregulate type II collagen and aggrecan synthesis through MAPK and Wnt/β-catenin pathway activation, suppress matrix-degrading enzymes (MMPs) through TIMP upregulation, and reduce inflammatory mediators in joint tissues through NF-κB inhibition—collectively promoting cartilage matrix deposition and repair while reducing destructive inflammation.


What to expect

  1. Days 1-14 (during treatment course)

    What you might notice

    • Minimal cardiovascular changes initially — vascular gene expression reprogramming is building
    • Possible mild headache or blood pressure fluctuation as endothelial function begins normalizing
    • Mild fatigue as vascular remodeling processes activate
    • Peptide-DNA binding at vascular gene promoters is activating extracellular matrix restoration programs

    What's normal

    • Vascular remodeling is a slow process — arterial stiffness doesn't resolve overnight
    • Cholesterol changes require hepatic and vascular gene expression changes that take weeks
    • eNOS upregulation and nitric oxide restoration develop gradually
    • Anti-inflammatory effects in vascular tissue are cumulative

    What's next

    • Continue daily administration for the full 10-20 day course
    • Lipid panel improvements typically become measurable 4-8 weeks after starting
    • Full vascular remodeling continues beyond the active treatment course
  2. Week 2-8 (during and after treatment)

    What you might notice

    • Gradual improvements in blood pressure readings
    • Better exercise tolerance and reduced exertional symptoms
    • Improved peripheral circulation (warmer extremities, better skin tone)
    • Measurable improvements in lipid panel on follow-up blood work

    What's normal

    • Arterial elasticity is improving through elastin/collagen normalization
    • Endothelial nitric oxide production is substantially enhanced
    • Vascular inflammatory markers are reducing
    • Cholesterol reduction (up to 30%) reflects hepatic gene expression changes

    What's next

    • Follow-up lipid panel recommended 6-8 weeks after treatment initiation
    • Benefits continue developing as vascular remodeling progresses
    • Plan next course in 3-6 months to maintain and extend cardiovascular improvements
  3. Month 2-6 (inter-course period)

    What you might notice

    • Sustained improvements in cardiovascular function and lipid profiles
    • Maintained blood pressure normalization and arterial compliance
    • Ongoing cardiovascular geroprotection from persistent vascular gene changes
    • Benefits may gradually diminish, indicating readiness for next course

    What's normal

    • Epigenetic modifications to vascular genes persist beyond the treatment course
    • Cyclical treatment every 3-6 months maintains and extends cardiovascular benefits
    • Each subsequent course reinforces vascular tissue normalization
    • Long-term follow-up demonstrates sustained cardiovascular protection over years

    What's next

    • Begin next Ventfort course after 3-6 months
    • Consider combining with complementary bioregulators (Epithalon, Vilon) in rotation
    • Regular cardiovascular monitoring (lipids, blood pressure, arterial stiffness) helps optimize treatment

Signs it's working

Treatment Response

  • Improvement in the primary symptoms or condition being treated
  • Positive changes in relevant lab values or clinical markers
  • Consistent, stable response to Ventfort over time
  • Reduction in symptom frequency or severity

Signs it's working

General Well-being

  • Improved energy levels and daily functioning
  • Better quality of life related to the treated condition
  • Manageable or absent side effects indicating good tolerance
  • Positive feedback from healthcare provider during check-ups

Not seeing results?

Common reasons

  • Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
  • Insufficient time at target dose—most compounds need several weeks to show full benefits
  • Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
  • Individual variation in response—genetics, metabolism, and other factors affect outcomes
  • Underlying conditions or medications interfering with absorption or effectiveness
  • Improper storage leading to degraded product—always verify proper storage conditions

What is Ventfort and how is it different from synthetic peptide bioregulators?

Ventfort is a tissue-derived peptide complex extracted from bovine aorta, containing a mixture of ultrashort peptides up to 5 kDa including the KED (Lys-Glu-Asp) tripeptide. Unlike purely synthetic single-peptide bioregulators (like Vilon/KE or Epithalon/AEDG), Ventfort provides a complex of multiple vascular-specific peptides that work together. This mirrors the approach of Thymalin (thymic extract) and Cortexin (brain extract) — tissue extracts that contain the full spectrum of organ-specific peptides rather than a single purified sequence.

How did the 49-patient trial demonstrate 30% cholesterol reduction?

In a controlled clinical study of 49 patients with cardiovascular conditions, Ventfort treatment resulted in approximately 30% reduction in total cholesterol levels over the treatment period. This effect is attributed to modulation of hepatic and vascular lipid metabolism gene expression through epigenetic mechanisms — the constituent peptides bind to DNA at promoters of genes controlling cholesterol synthesis, LDL receptor expression, and lipid transport, effectively reprogramming lipid metabolism at the gene level.

Can Ventfort replace statin medications?

Ventfort should not be considered a replacement for prescribed statin medications, particularly in patients with established cardiovascular disease or high cardiovascular risk. While the 30% cholesterol reduction observed clinically is comparable to moderate-intensity statin therapy, Ventfort lacks the extensive clinical trial evidence base that supports statins. It may be considered as adjunctive support alongside conventional therapy or for individuals who cannot tolerate statins, but always under medical supervision.

How does Ventfort restore arterial elasticity?

Arterial stiffness results from age-related changes in the vascular extracellular matrix — loss of elastin, increased collagen crosslinking, and dysregulated MMP activity. Ventfort's constituent peptides bind to gene promoters controlling elastin synthesis, collagen production, and MMP expression, rebalancing the extracellular matrix composition toward a more youthful elastic state. This is fundamentally different from vasodilators that temporarily relax vessel walls — Ventfort aims to reverse the structural changes in arterial walls.

What is the KED peptide found in Ventfort?

KED (Lys-Glu-Asp) is a tripeptide identified as one of the key active components in Ventfort's complex peptide mixture. It interacts with DNA minor groove at vascular gene promoter sequences, similar to how Vilon's KE dipeptide binds to GCGG sequences in immune genes. KED has been studied independently and shown to modulate vascular gene expression, but within Ventfort it works in concert with other aorta-derived peptides for comprehensive vascular bioregulation.

How does Ventfort fit into a comprehensive anti-aging protocol?

In Khavinson's bioregulator system, Ventfort addresses cardiovascular aging specifically. A comprehensive anti-aging protocol might include: Ventfort (vascular), Epithalon (pineal/melatonin), Vilon (immune), Cerluten (brain), and organ-specific peptides like Testagen (testicular) or Chonluten (lung) depending on individual needs. These are used in cyclical courses of 10-20 days, repeated every 3-6 months, with each peptide targeting its specific organ system through tissue-specific DNA binding.

Ready for the protocol?

Every dosing tier, administration route, timing note, and dose-adjustment rule for Ventfort, on one page.

Ventfort dosing protocol

Medical disclaimer

Ventfort is an investigational research compound not approved by the FDA for human therapeutic use. This information is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or treatment protocol.

Last updated: Oct 12, 2026

1 capsule (10 mg) once daily Once daily before meals or once or twice daily before meals or once daily · onset 3-4 weeks
Open the Ventfort calculatorVentfort calculator